Last reviewed · How we verify

Heliox21 — Competitive Intelligence Brief

Heliox21 (Heliox21) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Respiratory gas mixture. Area: Respiratory.

marketed Respiratory gas mixture Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Heliox21 (Heliox21) — University College, London. Heliox21 is a mixture of helium and oxygen used to reduce the work of breathing in patients with respiratory distress.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Heliox21 TARGET Heliox21 University College, London marketed Respiratory gas mixture

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Respiratory gas mixture class)

  1. University College, London · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Heliox21 — Competitive Intelligence Brief. https://druglandscape.com/ci/heliox21. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: